Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Working Capital/Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.330.590.840.751.06

What is the latest Working Capital/Sales ratio of GLAND PHARMA ?

The latest Working Capital/Sales ratio of GLAND PHARMA is 1.33 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.33
Mar20230.59
Mar20220.84
Mar20210.75
Mar20201.06

How is Working Capital/Sales of GLAND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.33
125.42
Mar2023 0.59
-29.76
Mar2022 0.84
12.00
Mar2021 0.75
-29.25
Mar2020 1.06 -

Other Financial Ratios of GLAND PHARMA


Compare Working Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹33,092.7 Cr 8% 15.8% -1.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,667.0 Cr 1.8% 3.4% 7.3% Stock Analytics
DIVIS LABORATORIES ₹180,131.0 Cr -0.7% 3.8% 49.3% Stock Analytics
CIPLA ₹119,745.0 Cr -0.2% -1.1% -2.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,603.0 Cr 5.8% 8.6% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,429.0 Cr 0.7% -3.8% -7.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

8%

15.8%

-1.5%

SENSEX

-1.1%

0.8%

2.2%


You may also like the below Video Courses